Plaza Heisei(Tokyo International Exchange Center Conference Hall)
Chairperson
Shinya Suzuki(National Cancer Center Hopsital East)
Peter Yap(National Cancer Center Singapore)
S1-1 Integrating Pharmacy in Oncology Clinical Practices in the United States
Speaker
Natasha Khrystolubova(NCODA Inc., Cazenovia, NY，Former Director of Pharmacy Clinical Services, Rx To Go，Florida Cancer Specialists & Research Institute，Current Director of Clinical Service for AllyGPO)
S1-2 Enhancing patients compliance and safety in ambulatory care
Speaker
Lita Chew(Group Chief Pharmacist, Singhealth，Director, Allied Health & Pharmacy, NCCS，Associate Professor, NUS，Senior Advisor, Ministry of Health)
S1-3 Collaborative and medically integrative clinical oncology pharmacy practice for safe and effective outpatient cancer treatment
Speaker
Takahiro Ohta(Ministry of Health, Labour and Welfare)
Plaza Heisei(Tokyo International Exchange Center Conference Hall)
Chairperson
Toyohito Oriyama(Department of Pharmacy, The University of Tokyo Hospital)
LS1 The Cutting Edge of Exposure Prevention Using Closed System Transfer Devises(CTSD)-The experience of Cancer Institute Hospital of JFCR, conducting Over 37,000 outpatient chemotherapy treatments annually
Speaker
Kazuo Kobayashi(Department of Pharmacy, The Cancer Institute Hospital of JFCR)
P-12 Association between adjuvant tegafur uracil plus calcium folinate efficacy and proton pump inhibitors in patients with stage II-III colorectal cancer
Speaker
Tadafumi Hoshida(Japanese Red Cross Wakayama Medical Center)
P-13 The study of pharmacotherapeutic strategies for cancer cachexia in advanced solid malignancy in Thailand
Speaker
Chatchanin Ajalanond(Pharm.D.)
P-14 Nausea and Vomiting Induced by 10-min and 60-min Dosing of Bendamustine in Patients with B-cell non-Hodgkin Lymphoma in Japan, A Single Center Retrospective Study
Speaker
Sakamoto Yasutaka(Department of Pharmacy, Yokohama City University Hospital)
P-15 Integrating artificial intelligence into the development of a chemotherapy wastage calculator
Speaker
Chew Lita(National Cancer Centre Singapore)
P-16 Immune-Related Adverse Events of PD-1/PD-L1 Inhibitors in Non-Small Cell Lung Cancer Patients Concomitantly Treated with Systemic Therapy: A Retrospective Study in a Hong Kong Hospital
Speaker
Keary Rui Zhou(The Chinese University of Hong Kong)
P-17 Comparative Retrospective Observational Study on Infusion-Related Reactions between Intravenous and Subcutaneous Formulations of Daratumumab
Speaker
Chinami Inoue(Gunma Prefectural Cancer Center)
P-18 The Role of Pharmacists in Managing Pneumocystis jirovecii Pneumonia Prophylaxis in Pediatric Patients with Acute Lymphoblastic Leukemia
Speaker
Sukmin Hong(Department of Pharmacy, Seoul National University Hospital)
P-19 The oncologic outcome of modified desensitization protocol for paclitaxel and carboplatin in gynecologic oncology patients
P-20 Retrospective Analysis of Mohs Paste Use in Patients with Skin Metastases at Yokohama Minami Kyosai Hospital
Speaker
Koji Hashiguchi( Yokohama Minami Kyosai HP Department of Pharmacy)
P-21 Evaluation of Dosing Guidelines on Empiric Amikacin Therapy in Patients with Hematologic Malignancy
Speaker
Soyeon Hong(Department of Pharmacy，Seoul National University Bundang Hospital)
P-22 Developing a Comprehensive Oncology Pharmacy Workplan: Integrating Enterprise Risk Management and Target Operating Model Principles
Speaker
Chui Mei Thum (National Cancer Centre Singapore )
P-23 Perioperative Methotrexate Management and Postoperative Infection in Non-Orthopedic Surgeries: A Study from Miyagi Cancer Center
Speaker
seiji miyaura(Department of Pharmacy, Miyagi Cancer Center)
P-24 Optimizing Medication Use in Terminal Cancer Patients: A Pharmacist-led Deprescribing Approach in Consultation-based Palliative Care Team
Speaker
Minoh Ko(College of Pharmacy，Research Institute of Pharmaceutical Sciences，Seoul National University，Department of Pharmacy，Seoul National University Hospital)
P-25 Comparison of Efficacy and Safety Between Bortezomib-lenalidomide-dexamethasone Therapy and Lenalidomide-dexamethasone Therapy in Patients with Multiple Myeloma
Speaker
Soyeon Hong(Department of Pharmacy，Seoul National University Bundang Hospital)
P-26 Preventive Effects of Non-Sedating Antihistamines Premedication on Subcutaneous Daratumumab-Associated Infusion-Related Reactions: A Prospective Cohort Study
Speaker
Mayu Suzukawa(Keio University Graduate School of Pharmaceutical Sciences)
P-27 Effects of hormonal therapy in patient with breast cancer on metabolic disorder; a retrospective cohort study.
Speaker
Nonthikun Pasukmoon(Department of Pharmaceutical, Sunpasitthiprasong Hospital)
P-28 A retrospective observational of thrombocytopenia incidence in solid tumor patient receiving chemotherapy at a tertiary care hospital, Thailand
Speaker
Manit Saeteaw(Faculty of Pharmaceutical Sciences, Khon Kaen University)
P-29 Development of a robust predictive model using L1 regularization and mixed-effects model for neutropenia after esophageal cancer chemotherapy
Speaker
Shuhei Sugaya(Graduate School of Pharmaceutical Sciences, Chiba University，Division of Pharmacy, Chiba University Hospital)
Plaza Heisei(Tokyo International Exchange Center Conference Hall)
Chairperson
Jung Tae Kim(Kyung Hee University Hospital at Gangdong)
Hirotoshi Iihara(Gifu University Hospital)
S2-1 Comparative Study of Osteoporotic Fractures (OF) and Pathologic Fractures (PF) in Patients with Metastatic Colorectal Cancer (mCRC) Undergoing Palliative Chemotherapy
Speaker
Kyungim Kim(Korea University)
S2-2 The role of pharmacists in research in the field of supportive care in cancer
Speaker
Yohei Iimura(IMSUT hospital)
S2-3 Dexamethasone-sparing with combined olanzapine in cisplatin: A Randomized Phase III Trial (SPARED Trial)
Speaker
Minatogawa Hiroko(St. Marianna University Hospital)
S2-4 Impact of Coronavirus Disease 2019 (COVID-19) on Healthcare Provision to the Elderly by Medical Personnel in a Tertiary Hospital: A Qualitative Study.
Speaker
Suthan Chanthawong(Faculty of Pharmaceutical Sciences, Khon Kaen University)
Symposium 3
Current status and future prospects of occupational exposure control
Plaza Heisei(Tokyo International Exchange Center Conference Hall)
Chairperson
BO YU(FUSCC)
Masami Tsuchiya(Keio University Faculty of Pharmacy)
S4-1 Development, Validation and Application of the Chinese Version of COmprehensive Scores according to Patient-Reported Outcome Measurement (COST-PROM) for Financial Toxicity in Chinese Cancer Patients
Speaker
Qian Jiang(Sichuan Cancer Hospital & Institute，Sichuan Cancer Centre，University of Electronic Science and Technology of China)
S4-2 The role of a clinical pharmacist in Taiwan
Speaker
Wei Hung Hung(Koo Foundation Sun Yat-Sen Cancer Center)
S4-3 Evaluation of pharmaceutical management and adverse events in oncology practice